Childhood ADHD Types & Treatments - Clinical Advisor

Childhood ADHD Types & Treatments

Slideshow

  • Childhood ADHD is comprised of three types: hyperactive/impulsive type, inattentive type and combined type. Symptoms may include inability to pay attention or sit still; impulsivity; trouble listening to a speaker, following directions, finishing tasks or keeping track of personal items; excessive talking; and difficulty playing quietly.

    ADHD Hyperactivity_ 0112 Slideshow

    Childhood ADHD is comprised of three types: hyperactive/impulsive type, inattentive type and combined type. Symptoms may include inability to pay attention or sit still; impulsivity; trouble listening to a speaker, following directions, finishing tasks or keeping track of personal items; excessive talking; and difficulty playing quietly.

  • Clinicians should advise the parents of children with ADHD to create well-structured routines at home to help their kids stay on task. Schedules should including specific times for waking up, eating, playing, homework, chores, activities and bedtime.

    ADHD Establishing Routine_0112 Slideshow

    Clinicians should advise the parents of children with ADHD to create well-structured routines at home to help their kids stay on task. Schedules should including specific times for waking up, eating, playing, homework, chores, activities and bedtime.

  • ADHD Medication Chart

    ADHD Trouble Focusing_0112 Slideshow

    Primary care clinicians should initiate ADHD evaluation in any child age 4 through 18 years of age that presents with academic or behavioral problems, and symptoms of inattention, hyperactivity or impulsivity for at least six months to a degree that is maladaptive and inconsistent with his or her age. Symptom onset should appear no later than age 7 years.

  • For elementary school–aged children aged 6 through 18 years old, primary care clinicians should prescribe FDA–approved ADHD medications, along with evidence-based parent and/or teacher-administered behavior therapy. The evidence is particularly strong for stimulant medications and sufficient but less strong for atomoxetine, extended-release guanfacine, and extended-release clonidine (in that order).

    ADHD Medication_0112 Slideshow

    For elementary school–aged children aged 6 through 18 years old, primary care clinicians should prescribe FDA–approved ADHD medications, along with evidence-based parent and/or teacher-administered behavior therapy. The evidence is particularly strong for stimulant medications and sufficient but less strong for atomoxetine, extended-release guanfacine, and extended-release clonidine (in that order).

  • Although the link between ADHD and television is unclear, the AAP recommends limiting young children’s exposure. The group discourages television viewing for children younger than 2 years and suggests no more than two hours a day for older children. Instead clinicians should recommend that parents encourage attention-building activities such as games, blocks, puzzles and reading.

    ADHD Limiting TV_0112 Slideshow

    Although the link between ADHD and television is unclear, the AAP recommends limiting young children’s exposure. The group discourages television viewing for children younger than 2 years and suggests no more than two hours a day for older children. Instead clinicians should recommend that parents encourage attention-building activities such as games, blocks, puzzles and reading.

  • For preschool-aged children, the American Academy of Pediatrics (AAP) recommends that clinicians prescribe evidence-based parent- and/or teacher-administered behavior therapy as first-line ADHD treatment. If evidence-based behavioral treatments are not available, clinicians should weigh the risks of starting medication at an early age against the harm of delaying diagnosis and treatment.

    ADHD Behavioral Therapy_0112 Slideshow

    For preschool-aged children, the American Academy of Pediatrics (AAP) recommends that clinicians prescribe evidence-based parent- and/or teacher-administered behavior therapy as first-line ADHD treatment. If evidence-based behavioral treatments are not available, clinicians should weigh the risks of starting medication at an early age against the harm of delaying diagnosis and treatment.

Attention-deficit hyperactivity-disorder (ADHD) is one of the most common neurobehavioral childhood disorders, according to the CDC. American Psychiatric Association data reveal that between 3% and 7% of U.S. school age children have some form of ADHD as defined by the Diagnostic and Statistical Manual of Mental Disorders criteria, and that prevalence has been increasing in recent years.

Approximately 2.7 million U.S. children aged 4 to 17 years, or about 66.3% of those with a current diagnosis, were receiving medications for the disorder in 2007, data from parent reports published in Morbidity and Mortality Weekly Report indicate. Read more about the disorder and recommended treatments in the slideshow below.

Next hm-slideshow in Slides